Insider Shareholders with Direct Ownership of Cumberland Pharmaceuticals Inc (CPIX)
This section provides a comprehensive overview of the insiders with direct ownership of Cumberland Pharmaceuticals Inc (CPIX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CUMBERLAND PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
A J Kazimi
Chairman and CEO |
46,697 | 141,028 | 5,698,738 $23.6 Million | 399 |
Mar 17, 2025
Reduced 0.06%
|
|
Kenneth Krogulski
Director |
112,942 | 0 | 282,843 $1.17 Million | 559 |
Mar 17, 2025
Added 1.39%
|
|
Martin E Cearnal
Sr VP/Chief Commercial Officer |
29,659 | 17,945 | 163,473 $678,412 | 174 |
Mar 17, 2022
Reduced 8.4%
|
|
Leo Pavliv
SVP and Chief Development Off. |
0 | 36,370 | 129,618 $537,914 | 2 |
May 31, 2022
Reduced 20.54%
|
|
Joey A Jacobs
Director |
10,000 | 5,000 | 98,415 $408,422 | 3 |
Jan 14, 2023
Reduced 4.83%
|
|
Joseph C Galante
Director |
29,004 | 0 | 61,856 $256,702 | 258 |
Mar 17, 2025
Added 1.59%
|
|
James Jones
Director |
27,477 | 0 | 42,646 $176,980 | 511 |
Mar 17, 2025
Added 2.29%
|
|
James L Herman
VP and Chief Compliance Office |
0 | 6,306 | 38,255 $158,758 | 4 |
Mar 23, 2024
Reduced 3.01%
|
|
Caroline Young
Director |
20,307 | 0 | 32,318 $134,119 | 567 |
Mar 17, 2025
Added 3.0%
|
|
John M. Hamm
VP Chief Financial Officer |
23,800 | 6,727 | 20,073 $83,302 | 5 |
Mar 16, 2025
Reduced 22.81%
|
|
Todd M. Anthony
Vice Pres Organizational Dev |
0 | 816 | 16,328 $67,761 | 1 |
Mar 23, 2024
Reduced 4.76%
|
|
Jonathan Griggs
Director |
1,000 | 0 | 14,803 $61,432 | 1 |
Mar 17, 2021
Added 6.33%
|
|
Michael Bonner
Chief Financial Officer |
0 | 8,567 | 11,720 $48,638 | 2 |
May 17, 2021
Reduced 39.02%
|
|
Martin S Brown Jr
Director |
3,000 | 0 | 8,500 $35,275 | 3 |
Mar 17, 2025
Added 10.53%
|
|
Chris T. Bitterman
Vice Pres Sales & Marketing |
0 | 593 | 4,683 $19,434 | 1 |
Mar 23, 2024
Reduced 11.24%
|